Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events
Author(s) -
Bariş Gencer,
TinhHai Collet,
Vanessa Virgini,
Douglas C. Bauer,
Jacobijn Gussekloo,
Anne Rentoumis Cappola,
David Nanchen,
Wendy P. J. den Elzen,
Philippe Balmer,
Robert Luben,
Massimo Iacoviello,
Vincenzo Triggiani,
Jacques Cornuz,
Anne B. Newman,
KayTee Khaw,
J. Wouter Jukema,
Rudi G. J. Westendorp,
Eric Vittinghoff,
Drahomir Aujesky,
Nicolas Rodondi
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.096024
Subject(s) - medicine , subclinical infection , hazard ratio , prospective cohort study , heart failure , confidence interval , cardiology , thyroid , thyroid function , endocrinology
American College of Cardiology/American Heart Association guidelines for the diagnosis and management of heart failure recommend investigating exacerbating conditions such as thyroid dysfunction, but without specifying the impact of different thyroid-stimulation hormone (TSH) levels. Limited prospective data exist on the association between subclinical thyroid dysfunction and heart failure events.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom